Adel Mekhail insider trades: Prestige Consumer Healthcare (PBH) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Adel reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 11, 2025 | PBH | ↓ Sell | 11,083 | $86.55 | $959K | Direct | Feb 13, 2025 (2d) |
| Nov 12, 2024 | PBH | ↓ Sell | 9,063 | $82.00 | $743K | Direct | Nov 14, 2024 (2d) |
| Feb 15, 2024 | PBH | ↓ Sell | 15,549 | $69.11 | $1.1M | Direct | Feb 20, 2024 (5d) |
| May 19, 2023 | PBH | ↓ Sell | 17,194 | $62.36 | $1.1M | Direct | May 22, 2023 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PBH insiders
Open-market trades in the last 12 months
About Adel Mekhail's insider trades
Adel Mekhail is EVP, Marketing & Sales at Prestige Consumer Healthcare (PBH). Since May 19, 2023, Adel has reported no open-market purchases and 4 sales worth $3.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include shares withheld for taxes (14 filings), grants and awards (11 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PBH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.